Results

RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/SHA-384/321BB8D1410C1F36EC95FB7B68198E37C2427BD23D2E762E9C1264D402902A5BC4EBD6C9D9F99D6A8B85E55E18F889CDhttp://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/321BB8D1410C1F36EC95FB7B68198E37C2427BD23D2E762E9C1264D402902A5BC4EBD6C9D9F99D6A8B85E55E18F889CDhttp://www.w3.org/2000/01/rdf-schema#comment"Study provide the first evidence that SEMA3C SEMA5A and SEMA6D can be considered as markers of liver injury in chronic hepatitis C. While serum concentrations of SEMA3C and SEMA6D significantly increased with fibrosis stage in both HCV-g1 and HCV-g3 infections the concentration of SEMA5A inversely correlated with fibrosis stage in both HCV genotypes."xsd:string
http://purl.uniprot.org/uniprot/#_F87F7EA4EF9E64E4C505A43378DAD3A112C1711B6BD1C61E33E6023C0943C55CF222573FE5E42728199C32AC5B1B74DDhttp://www.w3.org/1999/02/22-rdf-syntax-ns#subjecthttp://purl.uniprot.org/SHA-384/321BB8D1410C1F36EC95FB7B68198E37C2427BD23D2E762E9C1264D402902A5BC4EBD6C9D9F99D6A8B85E55E18F889CD
http://purl.uniprot.org/uniprot/Q75L25http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/321BB8D1410C1F36EC95FB7B68198E37C2427BD23D2E762E9C1264D402902A5BC4EBD6C9D9F99D6A8B85E55E18F889CD
http://purl.uniprot.org/uniprot/#_Q75L25-mappedCitation-30592759http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/321BB8D1410C1F36EC95FB7B68198E37C2427BD23D2E762E9C1264D402902A5BC4EBD6C9D9F99D6A8B85E55E18F889CD